St. Jude bird flu vaccine test successful

May 02, 2006

U.S. scientists say a commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus.

The research, conducted at St. Jude Children's Research Hospital in Memphis, Tenn., involved a vaccine developed by Vical Inc. of San Diego, Calif.

Richard Webby, an assistant faculty member in St. Jude's infectious diseases department, said the finding, coupled with results of previous studies, suggests such a vaccine would protect humans against multiple variants of the bird and human influenza viruses, including the H5N1 virus that might mutate so it can spread readily from person to person.

Flu experts and public health officials fear such an H5N1 variant would trigger a human pandemic.

Webby was to present the study Wednesday in Denver, Colo., during a U.S. Public Health Service Professional Conference.

Copyright 2006 by United Press International

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Researchers use microRNA to trap mutant viruses in the lab

Aug 12, 2013

(Phys.org) —It's a scenario straight out of a sci-fi horror flick. Scientists take a deadly virus that people can only catch from birds and genetically engineer it so we can give it to each other. Unfortunately, ...

Panel backs sharing studies of lab-made bird flu

Mar 30, 2012

(AP) -- The U.S. government's biosecurity advisers said Friday they support publishing research studies showing how scientists made new easy-to-spread forms of bird flu because the studies, now revised, don't reveal details ...

Controversial 'bird flu' edits move ahead

Dec 22, 2011

Top US scientists on Wednesday defended their bid to stop details of a mutant bird flu virus from being published and called for global cooperation to ward off an uncontrollable pandemic.

Recommended for you

New approach to particle therapy dosimetry

42 minutes ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Parkinson's disease reverted at a experimental stage

1 hour ago

Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide. The experiments ...

Putting the brakes on cancer

1 hour ago

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

Discovery of genes that predispose a severe form of COPD

1 hour ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.